Page last updated: 2024-08-24

venlafaxine hydrochloride and Hot Flashes

venlafaxine hydrochloride has been researched along with Hot Flashes in 60 studies

Research

Studies (60)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.33)	18.2507
2000's	27 (45.00)	29.6817
2010's	29 (48.33)	24.3611
2020's	2 (3.33)	2.80

Authors

Authors	Studies
Crandall, CJ; Manson, JE; Mehta, JM	1
Esfandbod, M; Etesam, F; Taleghani, SY	1
Anderson, GL; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; McCurry, SM; Morin, CM; Newton, KM; Otte, J; Reed, SD	1
Bates, C; Burns, RB; Reynolds, EE; Richardson, M	1
Deffenbacher, B; Lyon, C; Mullen, R; Nashelsky, J; Reed, A	1
Anderson, GL; Caan, B; Carpenter, JS; Cohen, LS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; Kroenke, K; Lacroix, AZ; Larson, JC; Newton, KM; Reed, SD; Sammel, MD; Sherman, S; Sternfeld, B	1
Fujii, T; Kobayashi, D; Natori, A; Okajima, Y; Yamaguchi, N	1
Adams, PT; Frizzell, B; Griffin, L; Lesser, GJ; Moose, D; Naughton, M; Radford, JE; Shaw, EG; Tomlinson, WV; Vitolins, MZ; Vuky, J	1
Cavanagh, J; Ferrell, W; Krishnadas, R; Lumsden, MA; Nicol, A; Pimlott, SL; Sassarini, J	1
Anderson, GL; Caan, B; Carpenter, JS; Cohen, L; Ensrud, KE; Freeman, EW; Guthrie, KA; Hunt, J; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Newton, KM; Reed, SD; Rexrode, KM; Shifren, J; Sternfeld, B	1
Handley, AP; Williams, M	1
Cohen, L; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Mitchell, CM; Newton, KM; Reed, SD; Shifren, JL	1
Caan, B; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Hohensee, C; Joffe, H; LaCroix, AZ; Landis, CA; Manson, J; Newton, KM; Otte, J; Reed, SD; Shifren, JL; Sternfeld, B; Woods, NF	1
Caan, B; Carpenter, JS; Cohen, LS; Ensrud, K; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Newton, K; Reed, S; Rexrode, K; Shifren, J; Sternfeld, B	1
Loprinzi, CL; Ruddy, KJ	1
Carpenter, JS; Kalesan, B; Pitta, DM; Ramaswami, R; Stebbing, J; Villarreal, MD	1
Anderson, GL; Caan, B; Carpenter, JS; Cohen, LS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Newton, KM; Reed, SD; Rexrode, K; Skaar, TC; Sternfeld, B	1
Asadi, M; Davari-Tanha, F; Hadizadeh, H; Shariat, M; Shirazi, M; Soleymani-Farsani, M	1
Crider, M; Hill, DA; Hill, SR	1
Banerjee, T; Barton, DL; Elkins, G; Keith, TZ; Schroeder, KCF; Wolf, S	1
Buijs, C; de Jong, RS; de Vries, EG; Marike Boezen, H; Maurer, JM; Mom, CH; Mourits, MJ; Nieboer, P; Willemse, PH; Wymenga, AN	1
Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V	1
Barton, DL	1
Bouchard, P; Irani, J; Mottet, N; Oba, R; Salomon, L	1
Ball, RM; Jakary, S; Kohn, B; Levine, RA; Nunez, R; Pegg, J; Peterson, E; Pocock, JR; Rodriguez, AI; Walker, EM	1
Levine, MN	1
Crystal, SC; Grosberg, BM; Hutchinson, S; Robbins, MS	1
Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM	1
Bordeleau, L; Ennis, M; Goodwin, PJ; Haq, R; Jugovic, O; Loprinzi, CL; Pritchard, KI; Warr, D	1
Adriaansz, S; Beijnen, JH; Boekhout, AH; Dalesio, OB; Foekema-Töns, JH; Nuijen, B; Schellens, JH; Sprangers, S; van den Bosch, J; Vincent, AD	1
Barton, DL; Loprinzi, CL; Qin, R	1
Girbig, D; Igl, BW; Lehmann, T; Obendorf, M; Patchev, VK; Prelle, K	1
Neher, JO; Sarkissian, A; Singh, R; St Anna, L	1
Gibson-Helm, M; Sayakhot, P; Teede, HJ; Vincent, A	1
Sleijfer, DT; Wymenga, AN	1
Bydder, SA; Spry, NA	1
Ansani, NT; Schober, CE	1
Goetz, MP; Loprinzi, CL	1
Barton, D; Loprinzi, CL	1
Stearns, V	1
Evans, ML; Jaffe, RB; McClish, K; Morgan, KS; Pritts, E; Vittinghoff, E	1
Bannink, M; Bontenbal, M; Seynaeve, C; van Gool, AR	1
Aronow, WS; Beck, G; Ness, J	1
Biglia, N; Cacciari, F; Kubatzki, F; Maggiorotto, F; Ponzone, R; Roagna, R; Sismondi, P; Torta, R	1
Adjei, AA; Atherton, P; Barton, DL; Carpenter, LA; Collins, M; Fitch, TR; Flynn, PJ; Loprinzi, CL; Mincey, BA; Rummans, TA; Shanafelt, TD; Sloan, JA	1
Beck, MG; Digmann, RR; Phillips, BB	1
Barton, D; Bearden, JD; Dakhil, SR; Fitch, TR; Kugler, JW; Levitt, R; Loprinzi, CL; Mailliard, JA; Nikcevich, DA; Sloan, JA; Tschetter, LK	1
Albertazzi, P	1
Azzouz, F; Carpenter, JS; Elam, JL; Johns, S; Johnson, CS; Monahan, PO; Shelton, RC; Storniolo, AM	1
Kaufmann, M; Loibl, S; Mehta, KM; Schwedler, K; Strohmeier, R; von Minckwitz, G	1
Baum, NH; Torti, DC	1
Dumesic, DA; Fonseca, R; Loprinzi, CL; Novotny, PJ; Perez, EA; Pisansky, TM; Quella, SK; Rummans, TA; Sloan, JA; Zahasky, KM	1
Antolak, SJ; Burch, PA; Loprinzi, CL; Novotny, P; Perez, EA; Pisansky, TM; Quella, SK; Sloan, J	1
Gottlieb, N	1
Barlow, DH	1
Barton, DL; Christensen, BJ; Dakhil, SR; Kugler, JW; LaVasseur, BI; Loprinzi, CL; Mailliard, JA; Novotny, PJ; Rodger, K; Rummans, TA; Sloan, JA	1
Grady-Weliky, TA; Hartmann, DM	1
Dvorak, SR	1

Reviews

15 review(s) available for venlafaxine hydrochloride and Hot Flashes

Article	Year
Management of Menopausal Symptoms: A Review. JAMA, 2023, 02-07, Volume: 329, Issue:5 Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism	2023
Clinical Inquiries: Does exercise relieve vasomotor menopausal symptoms? The Journal of family practice, 2018, Volume: 67, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Citalopram; Estrogen Replacement Therapy; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Menopause; Middle Aged; Sweating; Venlafaxine Hydrochloride; Yoga	2018
The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis. Journal of cancer research and clinical oncology, 2013, Volume: 139, Issue:10 Topics: Amines; Antineoplastic Agents, Hormonal; Cyclohexanecarboxylic Acids; Cyclohexanols; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Neoplasms, Hormone-Dependent; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2013
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review. Journal of the American Association of Nurse Practitioners, 2015, Volume: 27, Issue:1 Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride	2015
Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis. Breast cancer research and treatment, 2015, Volume: 152, Issue:2 Topics: Breast Neoplasms; Disease Management; Female; Hot Flashes; Humans; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2015
Hormone Therapy and Other Treatments for Symptoms of Menopause. American family physician, 2016, Dec-01, Volume: 94, Issue:11 Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride	2016
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. The American journal of psychiatry, 2008, Volume: 165, Issue:10 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride	2008
Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer? The Journal of family practice, 2012, Volume: 61, Issue:12 Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Constipation; Cyclohexanecarboxylic Acids; Cyclohexanols; Dizziness; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Off-Label Use; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2012
Management of hot flushes in breast cancer patients. Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:3 Topics: Adrenergic alpha-Agonists; Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Venlafaxine Hydrochloride	2002
A hot flash on tamoxifen metabolism. Journal of the National Cancer Institute, 2003, Dec-03, Volume: 95, Issue:23 Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohexanols; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluoxetine; Hot Flashes; Humans; Hydroxylation; Paroxetine; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Venlafaxine Hydrochloride	2003
Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clinical journal of oncology nursing, 2004, Volume: 8, Issue:1 Topics: Acetates; Activities of Daily Living; Algorithms; Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Decision Trees; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; Middle Aged; Nursing Assessment; Patient Selection; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Care; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2004
Management of hot flashes in breast cancer survivors and men with prostate cancer. Current oncology reports, 2004, Volume: 6, Issue:4 Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Noradrenergic and serotonergic modulation to treat vasomotor symptoms. The journal of the British Menopause Society, 2006, Volume: 12, Issue:1 Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride	2006
Managing hot flashes in men being treated for prostate cancer. Geriatrics, 2007, Volume: 62, Issue:11 Topics: Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Complementary Therapies; Cyclohexanols; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Megestrol Acetate; Orchiectomy; Prostatic Neoplasms; Testosterone; Venlafaxine Hydrochloride	2007
Beyond estrogen: new alternatives for the management of hot flashes. South Dakota journal of medicine, 2002, Volume: 55, Issue:1 Topics: Cyclohexanols; Estrogens; Estrogens, Non-Steroidal; Female; Hot Flashes; Humans; Isoflavones; Middle Aged; Phytoestrogens; Placebos; Plant Preparations; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2002

Trials

25 trial(s) available for venlafaxine hydrochloride and Hot Flashes

Article	Year
Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer. Drug research, 2023, Volume: 73, Issue:8 Topics: Adult; Aged; Breast Neoplasms; Citalopram; Double-Blind Method; Female; Hot Flashes; Humans; Menopause, Premature; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride	2023
Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials. Sleep, 2018, 01-01, Volume: 41, Issue:1 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cognitive Behavioral Therapy; Double-Blind Method; Estradiol; Exercise; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Meditation; Menopause; Middle Aged; Outcome Assessment, Health Care; Placebos; Self Report; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride; Yoga	2018
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Nov-10, Volume: 31, Issue:32 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyclohexanols; Double-Blind Method; Hot Flashes; Humans; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Soybean Proteins; Venlafaxine Hydrochloride	2013
Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women. Maturitas, 2014, Volume: 77, Issue:3 Topics: Aged; Brain; Cyclohexanols; Endothelium, Vascular; Female; Hot Flashes; Humans; Microvessels; Middle Aged; Postmenopause; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Skin; Tomography, Emission-Computed, Single-Photon; Venlafaxine Hydrochloride	2014
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA internal medicine, 2014, Volume: 174, Issue:7 Topics: Adult; Cyclohexanols; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2014
Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial. Obstetrics and gynecology, 2014, Volume: 124, Issue:2 Pt 1 Topics: Adult; Cyclohexanols; Double-Blind Method; Dyspareunia; Estradiol; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Orgasm; Perimenopause; Postmenopause; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Vagina; Venlafaxine Hydrochloride	2014
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes. Sleep, 2015, Jan-01, Volume: 38, Issue:1 Topics: Cyclohexanols; Double-Blind Method; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Perimenopause; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride	2015
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause (New York, N.Y.), 2015, Volume: 22, Issue:6 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Postmenopause; Quality of Life; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2015
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstetrics and gynecology, 2015, Volume: 126, Issue:2 Topics: Citalopram; Cyclohexanols; Dietary Supplements; Double-Blind Method; Estradiol; Estrogens; Exercise; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Middle Aged; Monitoring, Physiologic; Outcome Assessment, Health Care; Perimenopause; Postmenopause; Selective Serotonin Reuptake Inhibitors; Vasomotor System; Venlafaxine Hydrochloride; Yoga	2015
Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial. Archives of gynecology and obstetrics, 2016, Volume: 293, Issue:5 Topics: Citalopram; Depression; Double-Blind Method; Female; Hot Flashes; Humans; Iran; Middle Aged; Postmenopause; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Severity of Illness Index; Sleep; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	2016
Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study. Menopause (New York, N.Y.), 2017, Volume: 24, Issue:7 Topics: Antidepressive Agents, Second-Generation; Biobehavioral Sciences; Combined Modality Therapy; Double-Blind Method; Female; Hot Flashes; Humans; Hypnosis; Middle Aged; Pilot Projects; Treatment Outcome; Venlafaxine Hydrochloride	2017
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. Breast cancer research and treatment, 2009, Volume: 115, Issue:3 Topics: Adrenergic alpha-Agonists; Adult; Breast Neoplasms; Clonidine; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Treatment Outcome; Venlafaxine Hydrochloride	2009
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. The Lancet. Oncology, 2010, Volume: 11, Issue:2 Topics: Adenocarcinoma; Androgen Antagonists; Autonomic Agents; Cyclohexanols; Cyproterone Acetate; Double-Blind Method; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Treatment Outcome; Venlafaxine Hydrochloride	2010
Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-01, Volume: 28, Issue:4 Topics: Acupuncture Therapy; Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Postmenopause; Prognosis; Quality of Life; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Treatment Outcome; Venlafaxine Hydrochloride	2010
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-10, Volume: 28, Issue:35 Topics: Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cross-Over Studies; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Middle Aged; Patient Preference; Surveys and Questionnaires; Survivors; Treatment Outcome; Venlafaxine Hydrochloride	2010
Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Oct-10, Volume: 29, Issue:29 Topics: Adult; Aged; Analgesics; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2011
Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstetrics and gynecology, 2005, Volume: 105, Issue:1 Topics: Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Hot Flashes; Humans; Libido; Postmenopause; Quality of Life; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2005
Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors. Maturitas, 2005, Sep-16, Volume: 52, Issue:1 Topics: Adolescent; Adult; Breast Neoplasms; Cyclohexanols; Drug Administration Schedule; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Survivors; Treatment Outcome; Venlafaxine Hydrochloride	2005
Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. Journal of palliative medicine, 2005, Volume: 8, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Female; Hot Flashes; Humans; Middle Aged; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride	2005
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Mar-20, Volume: 24, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cyclohexanols; Drug Therapy, Combination; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2006
Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. The oncologist, 2007, Volume: 12, Issue:1 Topics: Adult; Breast Neoplasms; Cyclohexanols; Disease-Free Survival; Double-Blind Method; Female; Hot Flashes; Humans; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2007
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:4 Topics: Adult; Aged; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2007
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Cyclohexanols; Female; Hot Flashes; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	1998
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. The Journal of urology, 1999, Volume: 162, Issue:1 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antidepressive Agents, Second-Generation; Cyclohexanols; Hot Flashes; Humans; Male; Middle Aged; Pilot Projects; Prostatic Neoplasms; Severity of Illness Index; Venlafaxine Hydrochloride	1999
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet (London, England), 2000, Dec-16, Volume: 356, Issue:9247 Topics: Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride	2000

Other Studies

20 other study(ies) available for venlafaxine hydrochloride and Hot Flashes

Article	Year
Should This Patient Receive Hormone Therapy for Her Menopausal Symptoms?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals of internal medicine, 2018, 02-06, Volume: 168, Issue:3 Topics: Antidepressive Agents, Second-Generation; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Quality of Life; Risk Assessment; Sleep Wake Disorders; Venlafaxine Hydrochloride	2018
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:1 Topics: Biomedical Research; Citalopram; Cyclohexanols; Dietary Supplements; Double-Blind Method; Estradiol; Estrogens; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Menopause; Outcome Assessment, Health Care; Patient Selection; Placebos; Quality Control; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Sweating; Time Factors; Venlafaxine Hydrochloride; Yoga	2014
Antidepressants decrease hot flashes and improve life quality. Menopause (New York, N.Y.), 2015, Volume: 22, Issue:6 Topics: Estradiol; Female; Hot Flashes; Humans; Postmenopause; Quality of Life; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2015
Menopausal symptoms following tamoxifen treatment for breast cancer. Oncology (Williston Park, N.Y.), 2008, Volume: 22, Issue:4 Suppl Nu Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride	2008
Conventional and complementary therapies: a tale of two research standards? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Apr-20, Volume: 28, Issue:12 Topics: Acupuncture Therapy; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Complementary Therapies; Cyclohexanols; Deoxycytidine; Dietary Supplements; Evidence-Based Medicine; Gemcitabine; Hot Flashes; Humans; Neoplasms; Peptide Hydrolases; Risk Assessment; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2010
Teaching case: menopausal migraine. Headache, 2010, Volume: 50, Issue:2 Topics: Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Herbal Medicine; Hot Flashes; Humans; Menstrual Cycle; Menstruation Disturbances; Middle Aged; Migraine Disorders; Postmenopause; Topiramate; Venlafaxine Hydrochloride	2010
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause (New York, N.Y.), 2010, Volume: 17, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins	2010
Nonestrogenic management of hot flashes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Oct-10, Volume: 29, Issue:29 Topics: Breast Neoplasms; Clonidine; Cyclohexanols; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride	2011
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:8 Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Diurnal Enuresis; Drug Discovery; Estradiol; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Hypnotics and Sedatives; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Venlafaxine Hydrochloride	2012
Differences in clinician understanding and management of early menopause after breast cancer. Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:4 Topics: Anxiety; Australia; Breast Neoplasms; Cross-Sectional Studies; Cyclohexanols; Depression; Endocrinology; Exercise; Female; Follicle Stimulating Hormone; General Practitioners; General Surgery; Gynecology; Hot Flashes; Humans; Life Style; Medical Oncology; Menopause, Premature; Practice Patterns, Physicians'; Surveys and Questionnaires; Venlafaxine Hydrochloride	2013
Treatment for hot flushes in women receiving tamoxifen. The Medical journal of Australia, 2002, Sep-02, Volume: 177, Issue:5 Topics: Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride	2002
Treating hot flashes with drugs: an update. Harvard women's health watch, 2002, Volume: 9, Issue:12 Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Venlafaxine Hydrochloride	2002
Venlafaxine hydrochloride for the treatment of hot flashes. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:11 Topics: Clinical Trials as Topic; Cyclohexanols; Female; Hot Flashes; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2003
Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer. The Netherlands journal of medicine, 2005, Volume: 63, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Cyclohexanols; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride	2005
Menopausal symptoms after cessation of hormone replacement therapy. Maturitas, 2006, Feb-20, Volume: 53, Issue:3 Topics: Administration, Topical; Aged; Attitude to Health; Chi-Square Distribution; Complementary Therapies; Cyclohexanols; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Postmenopause; Prevalence; Retrospective Studies; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2006
Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hot Flashes; Humans; Liver Function Tests; Middle Aged; Postmenopause; Venlafaxine Hydrochloride	2006
Nonhormonal agents show promise against hot flashes. Journal of the National Cancer Institute, 2000, Jul-19, Volume: 92, Issue:14 Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Contraindications; Controlled Clinical Trials as Topic; Cyclohexanols; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Male; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2000
Venlafaxine for hot flushes. Lancet (London, England), 2000, Dec-16, Volume: 356, Issue:9247 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Hot Flashes; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2000
Breast cancer and hot flashes. Options for relief. Mayo Clinic health letter (English ed.), 2001, Volume: 19, Issue:3 Topics: Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Flushing in a menopausal woman taking venlafaxine. The American journal of psychiatry, 2001, Volume: 158, Issue:8 Topics: Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Flushing; Hot Flashes; Humans; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001